Dienogest

In: Reactions Weekly · 2018 · vol. 1725(1) , pp. 120 · doi:10.1007/s40278-018-53461-2 · W4247431561
article OA: closed CC0
Full text JSON View on OpenAlex View at publisher
⚙ AI-generated summary by claude@2026-06+body, 2026-06-09 ⓘ

Dienogest therapy during early endometrioma recurrence may serve as an alternative to repeat surgeries.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

⚙ AI-generated deep summary by claude@2026-06, 2026-06-09 · read from full text ⓘ

This report discusses Koshiba and colleagues’ 2018 study examining dienogest treatment during early stages of recurrence of endometrioma, aiming to avoid repeat surgeries after initial endometrioma management. The paper is based on clinical experience/data from Japan and evaluates whether dienogest could serve as an alternative option during recurrence. The key finding described is that early-stage recurrent endometrioma patients treated with dienogest may be managed without immediate repeat surgery, though the publication format in this excerpt does not provide detailed methods, sample size, or outcome effect estimates. This paper is centrally about endometriosis — it focuses on dienogest therapy for early recurrence of endometrioma.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Full text 550 characters · extracted from oa-doi-fallback · click to expand
Reference Koshiba A, et al. Dienogest therapy during the early stages of recurrence of endometrioma might be an alternative therapeutic option to avoid repeat surgeries. Journal of Obstetrics and Gynaecology Research 44: 1970-1976, No. 10, Oct 2018. Available from: URL: http://doi.org/10.1111/jog.13725 - Japan Rights and permissions About this article Cite this article Dienogest. Reactions Weekly 1725, 120 (2018). https://doi.org/10.1007/s40278-018-53461-2 Published: Version of record: Issue date: DOI: https://doi.org/10.1007/s40278-018-53461-2

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

⚙ Ask this paper AI returns verbatim quotes from the full text · source: oa-doi-fallback ⓘ

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Citation neighborhood (sparse)

Too few in-corpus citations on either side for a chart; here are the lists.

Cites (1)

References (1)

Source provenance

openalex
last seen: 2026-05-10T10:20:29.515715+00:00
unpaywall
last seen: 2026-06-14T06:15:46.576397+00:00
License: CC0 · commercial use OK